Unlocking NATURE potential
Harnessing AI and nature to redefine the pace of drug discovery, uncovering bioactive compounds with unprecedented precision and speed.
Our Story / Our Technology / Impact / Our Partners /
Our Story / Our Technology / Impact / Our Partners /
Our Story / Our Technology / Impact / Our Partners
Our Story
Nature has always been humanity’s greatest teacher, and for us, it is deeply woven into our history, culture, and daily life. For centuries, the healing power of plants has been a cornerstone of wellness across generations in Asia.
At NYB, we honor this legacy by uniting centuries of cultural wisdom with groundbreaking innovation. Leveraging state-of-the-art AI technologies and scientific expertise, we uncover nature’s hidden treasures—bioactive compounds that hold the potential to transform billions of lives.
At NYB, we honor this legacy by uniting centuries of cultural wisdom with groundbreaking innovation. Leveraging state-of-the-art AI technologies and scientific expertise, we uncover nature’s hidden treasures—bioactive compounds that hold the potential to transform billions of lives.
Our Techonology
Building on this heritage, we developed DTIGN—our proprietary Drug-Target Interaction Graph Neural Network. DTIGN represents the future of drug discovery by simulating molecular interactions at the atomic level, enabling unparalleled identification of bioactive compounds with transformative potential.
Our Techonology
By blending nature’s insights with advanced technology, we accelerate the discovery of compounds that power the next generation of health and wellness products.
Impact
2B+
compound library
64x
higher hit rates than the most popular docking software
10M+
natural compounds
44.83%
increase in bioactivity prediction efficiency
Our Partner
To us, partnership means possibility. We work closely with visionary organizations to uncover groundbreaking solutions from nature’s untapped potential. By integrating our advanced AI capabilities with the expertise and goals of our partners, we accelerate bioactive compound discovery beyond industry standards.
Press & media
Company
Nanyang Biologics is the Winner of SuperAI Genesis 2025
Nanyang Biologics has been crowned the 1st Prize Winner of the SuperAI Genesis Startup Competition 2025, the world’s premier AI startup showdown at SuperAI Singapore 2025.
Company
Nanyang Biologics Featured in NVIDIA’s Global Startup Showcase at GTC Taipei 2025
We’re incredibly excited to share that Nanyang Biologics has been featured in the NVIDIA’s official video spotlighting standout startups at NVIDIA GTC Taipei 2025.
.jpg)
Press
[Computer Weekly] Pharma leaders see AI revolutionising medicine
NYB AI is featured in Computer Weekly’s coverage of Gitex Asia 2025, where industry leaders discussed how AI is revolutionizing drug discovery and development.
Featured news
Company
Nanyang Biologics Featured in Equinix Global Case Study on AI-Powered Drug Discovery
Nanyang Biologics has been featured as a global case study by @Equinix, showcasing how our AI-driven drug discovery is powered by scalable and secure infrastructure.
.jpg)
Partnership
NYB.AI and Pnaseer Inc. Announce Strategic Partnership to Advance AI-Powered Hair Regeneration Research
NYB.AI and Pnaseer Inc. have entered a strategic partnership to accelerate hair follicle regeneration research by combining AI-powered compound prediction with advanced bio-nanoparticle drug delivery.
Company
Nanyang Biologics is the Winner of SuperAI Genesis 2025
Nanyang Biologics has been crowned the 1st Prize Winner of the SuperAI Genesis Startup Competition 2025, the world’s premier AI startup showdown at SuperAI Singapore 2025.
